Tel. +44 (0)20 7287 4414
Tel. +44 (0)20 7287 4414
The Bruges Group spearheaded the intellectual battle to win a vote to leave the European Union and, above all, against the emergence of a centralised EU state.
The Bruges Group spearheaded the intellectual battle to win a vote to leave the European Union and, above all, against the emergence of a centralised EU state.

Bruges Group Blog

Spearheading the intellectual battle against the EU. And for new thinking in international affairs.

Who's Supporting the WHO?

vaccine-6649559_128_20240523-100335_1 Inject the World?

 The World Health Organisation, with the support of governments, public-private agencies, profit-seeking multinational corporations, academic institutions, charities and foundations, has been allowed to become a medium for the international marketisation of medical tech and vaccines, and, if we are not careful, the use of these may become mandatory should its Director declare some newly minted virus is causing a pandemic.

Established in April 1948, the role of the WHO has morphed, particularly over recent years, from an advisory to a managerial one, reflecting the increasing involvement of powerful agents and wealthy commercial interests. This is shown clearly in last year's WHO's list of Contributors.

The following gives an outline of the most influential Contributors in this list whose work continues into 2024.

The Bill and Melinda Gates Foundation (BMGF) and Gavi have serious financial interests in vaccinations – their development, sale to governments, especially of low and middle income countries and in the education and training of young people in order to perpetuate the manufacture and distribution of these vaccines. Bill Gates has boasted that his vaccines involvement is 'the best investment I've ever made' having made $200 billion from $10 billion.

The BMGF raises big money with its portfolio of $42 billion in stocks and shares in FedEx, Walmart, Coca-Cola, FEMSA, Ecolab, Deere, Caterpillar, Waste Management, Canadian National Railway, Berkshire Hathaway and, of course, Microsoft.

Let money be made but not by hiding risks to the health of people using the products or affecting countries' economic development.

CEPI (Coalition for Epidemic Preparedness Innovations) was co-founded by Sir Jeremy Farrar 'as a mechanism for promoting and funding epidemic vaccines.'

Together with the BMGF and Aspen, CEPI aims 'to reduce the time for regulatory review of new vaccine candidates' to be ready for Disease X to ensure access and development of vaccines and other biological countermeasures 'favourable for LMICs … with the ultimate objective to develop a broadly protective Betacoronavirus vaccine.'

'Leveraging more priority pathogens to further develop and characterise platforms to enable rapid development of vaccines or monoclonal antibodies and using such innovative technologies to develop vaccines against viable targets of value to LMICs with a path to licensure and WHO prequalification.'

'Processes guiding investments and decision-making will also need to be adapted to the needs of the next business cycle.'

2022-2026 funding needs appx. US$3.5 to 4 billion.

Gavi The Vaccine Alliance

'Gavi will make the case for donors to invest in a new era of vaccination.' Funding will be sought 'to protect communities by strengthening primary health care, shield them from the growing effects of climate change and play a foundational role in global health security.' Gavi plans 'to introduce and scale up the

widest portfolio of vaccines in its history...'

The approach used is to push the fearful idea of an emergency which then requires powerful people to get busy saving everyone by pushing their products. This actually happened when the Emergency Use Authorisation for the Covid mRNA jabs rollout was proclaimed in America. In Britain, guilt-tripping, gas-lighting and propaganda were used by authorities to increase fear and panic and promote compliance to masking, lockdowns, vaccines and enforced and self-imposed isolation. 'Disobedient' people were arrested in many countries.

This policy of arousing a sense of urgency, even where none exists, continues to be used by those working to promote the manufacture and marketing of mRNA jabs, new medicines, health tech and diagnostic procedures. In the near future, this urgency will be propagated in particular at primary healthcare levels in what used to be called poor regions of the world, now termed L&MICs (Low & Middle Income Countries), where people may know less about the science, economics and politics behind the medicines and injections they are given. Thus, the message revealed in the WHO 2024 documents published a few days ago and linked below is that urgent preparations must be made before we are hit by the next pandemic.

Since the rollout of the mRNA jabs, a huge quantity of evidence-based research has been done of its effects on people's health. One would hope that some of the findings would have been used in the WHO's programme for 2024. However, this is not the case.

Of great concern is that without a single reference to the proven side-effects, serious injuries and deaths caused by them, the development and marketing plans for mRNA jabs in Nigeria, Kenya and Bangladesh, for example, are stated as plans set in stone:

Preparations were laid last year and will be developed further this year. mRNA jabs for Nigeria mRNA jabs for Kenya mRNA jabs for Bangladesh

Focussing again on those LICs in Africa and Asia and infectious diseases, the Wellcome Trust wants to 'drive a paradigm shift from a predictive and preventative approach' to 'create a new generation of affordable products & tools, and facilitate their implementation and hence their impact.'

Of great concern too is that the Wellcome Trust has funded scientists (for example, Ralph Baric, currently giving mendacious evidence to a Congressional Enquiry) who do their best to cover up the fact that the covid virus was created in and escaped from a lab; instead, pushing the idea backed by spurious data, that the virus and the responses demanded that killed millions, crashed economies and caused immeasurable harms to young and old, jumped all of a sudden from insectivorous bats to homo sapiens.

Indeed, this focus on zoonotic or 'spill over' potential is invaluable, not only for unethical scientists seeking funding but also for investors and businesses seeking to profit from an endless stream of viruses against which to organise diagnostic tests and manufacture and sell vaccines, medication and health technology. The Global Virome Project has accumulated a vast collection of data about viruses from the wild (for scientists to manipulate at will?)

Its director Dennis Carroll using USAID money, is founder, director, financial beneficiary of the GVP as well as top funder of the Wuhan Institute of Virology. To some, he 'illustrate(s) the venal, specious and fraudulent foundations of the central assumption behind the PPR (Pandemic Preparedness & Response) immensely profitable new industry...' Apart from the GVP, Bill Gates, Big Pharma and the mass media, Robert Kennedy Jr. in his book The Wuhan Cover-Up also condemns 'the medical/military-industrial complex' and 'an intrusive and repressive surveillance infrastructure, enabling the systematic dismantling of constitutional rights and imposition of repressive social controls'...which enable the creation of 'a pipeline of pandemic-ready superbugs for an endless parade of pandemic emergencies with each corporate partner ready to roll out instantaneous mRNA vaccines.'

The GVP does not appear on the WHO's 2023 list. However, it is featured in the World Bank's Analysis of Pandemic Preparedness and Response (PPR) architecture, financing needs, gaps and mechanisms Prepared for the G20 Joint Finance & Health Task Force.

In Annex A p.29 Table 7, the GVP appears as THE organisation to be funded to carry out the task of surveilling for 'zoonotic viral threats' estimating that it needs US$ 0.2 billion over 10 years for this task.

If there is any danger from zoonotic viral threats, it is very rare. The main danger would be from viruses created by scientists. Are taxpayers ready to fund those who, having invented a problem need funds for the envisioned 'mitigating measures'? Still worse, is when these measures cause harm or are just wasted (reminding one of efforts to save the planet by decarbonising our economies.)

The Wellcome Trust is the world's third largest foundation after Novo Nordisk and the BMGF.

Apart from funding scientists and commercial medical interests, it liaises between the British government and pharma lobbyists, controls international public health regulators like the WHO, SAGE, Gavi and CEPI and has financial involvement in UK charities, pensions and some government departments and a UK and US property portfolio of nearly £1.6 billion (p.182). It is a strategic partner of the World Economic Forum and banks with HSBC and JP Morgan and makes grants to 21 academic institutions (p.145) and UK organisations (p.173)

'During the year, Wellcome incurred £0.4 million in expenditure relating to a partnership between Wellcome, the UK Medical Research Council, the UK Foreign, Commonwealth and Development Office and the UK Department of Health to fund global health trials in low- and middle-income countries. Subject to review and approval of appropriate costed extensions, Wellcome may contribute up to a further £2.5 million over the next four years....

Subject to review and approval of appropriate costed extensions Wellcome may contribute up to £2.0 million over the next three years....'

Wellcome works in 'partnership with the British Heart Foundation, Cancer Research UK, Scottish Ministers acting through their Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Engineering and Physical Sciences Research Council, Medical Research Council, Natural Environment Research Council, Department of Health and Social Care acting through its National Institute for Health Research, Health and Social Care Research and Development Division, Welsh Government, Public Health Agency and The Health Foundation to fund research into population-level strategies that will prevent non-communicable diseases and reduce inequalities in health. Wellcome may contribute up to £0.9 million over the next three years.'

The Wellcome Trust also owns Genome Research Limited

GRL is chaired by Sir Jeremy Farrar who is also Chief Scientist at the WHO since 2023 having left his positions as CEO of the Wellcome Trust and member of its Investment Committee earlier that year. Sir Jeremy Farrar has indeed dedicated his working life to the promotion and funding of epidemic vaccines as his worldwide networking and connections reveal.

The Bloomberg Family Foundation was another contributor to the WHO last year. This Foundation has also given funds to the John Hopkins Centre for Health Security, previously known as the Gates and NIH funded JH Centre for Civilian Biodefense Strategies. Links between bioweapons and pandemics have been discussed by Robert Kennedy in his book The Wuhan Cover-up (pp.94-98.) Sanofi-Aventis was a contributor whose R&D is 'for delivering medicines and vaccines for millions of people around the world.'

In collaboration with the WHO Foundation and the Clinton Global Initiative, the Global Health Equity Fund was established. 'The GHEF is a $200 million unique financial-first impact venture capital investment fund, focusing on breakthrough technology solutions that can impact healthcare globally. It will fuel innovation and increase investment in the health sector, with the shared goals of delivering competitive returns to investors and ensuring equitable access to medical care.'

World Organisation for Animal Health

The 'One Health Approach' slogan makes a significant appearance with the WOAH in regard to animals (wild and domestic) re-inforced by the relentless (and spurious) claims of the 'spill over' of viruses to humans. In the WHO's 2024 agenda, it reappears, with an emphasis on antimicrobial resistance or AMR, an issue stimulating much research.

The Rockefeller Foundation claims that 'Climate change is affecting human pathogenic diseases' and another agency in the 2023 WHO list, the Foundation for Innovative New Diagnostics (FIND)

based in Geneva, Cape Town, Nairobi and Hanoi, focusses on diagnostic testing and pandemic threats and on genomic sequencing capacity

FIND's partners include government donors, philanthropic organizations, commercial companies, academic and research institutions, international public health organizations, NGOs, health ministries and disease control programmes.

Donors include BMGF, CDC, CEPI, EU, Gavi, The Rockefeller Foundation, UKAID, USAID, Wellcome Trust and the WHO. FIND is also included as a possible beneficiary of a World Bank fund for 'providing catalytic investments in areas of PPR that are underserved.' p.25 of the document cited above prepared by the WHO and World Bank in March 2022.

UK Health Security Agency is in the WHO's 2023 list As of April 29th 2024, the UKHSA continues to offer 'Covid-19 vaccinations.' The International Vaccine Institute (IVI) is a partner of the Global Health Technology Coalition.

University Research Co.LLC whose partners include USAID, CDC, BMGF and the WHO. with a video showing the use of vaccinations to treat covid (2:14)

Gates Ventures, Limited Liability Company

Gates Ventures consultants are McKinsey who advise companies, even competing ones, how best to make money, usually by privatising public assets.

'McKinsey served as a knowledge partner to Gates Ventures' Exemplars in Global Health program to help identify digital solutions for primary healthcare across low- and middle income countries...'

CRDF Global The Civilian Research and Development Foundation

Affiliated Expert, Biosecurity – Mayra Ameneiros who is 'a Senior Fellow at the International Biosecurity and Biosafety Initiative for Science. She holds a BSc and MSc in Biochemistry, and is a certified professional in biorisk management and biosecurity accredited by IFBA, where she has also acted as a Mentor of the IFBA Global Mentorship Program. Ameneiros is a member of the WHO Health-Security Interface Technical Advisory Group (HSI-TAG), providing independent advice to WHO on strategic priorities and plans of action related to the health-security interface, including preparedness and response to deliberate events and chemical, biological, radiological, and nuclear threats.'

Affiliated Expert, Global Security – David Todding 'internationally recognized as one of the world's most experienced Open Source Intelligence (OSINT) professionals' with 'front-line experience in national security, counterterrorism, police and military operations' ... working 'internationally with government, NGO and private sector clients … David is a member of the Safe Ukraine 2030 Expert Council in Kyiv, a Special Advisor to the International Chamber of Commerce Commercial Crime Section in London and a Strategic Advisor to Cyb3r Operations, a UK based technology company providing Cyber Threat Assessment solutions.

Technical Director, Global Health – Julie Fischer She 'brings extensive experience in infectious diseases research, laboratory systems strengthening, and public health preparedness to the organization...She led a multidisciplinary team to promote evidence-based biosafety and biosecurity practices, and to help partner nations strengthen their capacities to detect and characterize disease threats rapidly, reliably, accurately, and safely.'

Thirty four partners are listed.

China Medical Board

Founded by the Rockefeller Foundation in 1914, the CMB provides grants to 'international groups wishing to work in China to establish relationships directly with CMB-affiliated Chinese and Asian institutions.'

It aims to promote digital tech use in healthcare.

UN Foundation and its pandemic treaty plans can be found here:

The CDC Foundation as a US Government-established yet independent organisation that also was a WHO Contributor last year.

The Foundation was set up to enable America's Centers for Disease Control and Prevention to work with the private sector, to strengthen laboratories, surveillance systems, workforce and emergency management capabilities. It 'has prioritized expanding equitable access to vaccines, which will help strengthen global health security.'

'Nowhere is this work more important than in the development of vaccines.'

The Global Health Security Agenda (GHSA) 2024 Framework has an online video where the claim is made that 75% of all emerging infectious diseases are caused by humans coming into contact with wildlife, including covid.

In 2018, the GHSA, invited other countries to join the Global Partnership. 'The Global Partnership has identified strengthening biological security as a key priority for collective programming efforts, and pursues activities that aim to: secure and account

for materials that represent biological proliferation risks; develop and maintain appropriate and effective measures to prevent, prepare for, and respond to the deliberate misuse of biological

agents; strengthen national and global networks to rapidly identify, confirm and respond to biological attacks; reinforce and strengthen biological non-proliferation principles, practices and instruments; and reduce proliferation risks through the advancement and promotion of safe and responsible conduct in the biological sciences.' (p.35)

The pre-pandemic date as well as the references to 'stakeholders' arouses suspicions of pre-planning, Klaus Schwab's desire to establish 'stakeholder capitalism' and a preoccupation with biosecurity rather than public health.

Academic institutions in WHO's 2023 Contributors list include

John Hopkins University (Gates funded part is the Centre for Health Security)

sponsored by:

of the Bloomburg School of Public Health:

Karolinska Institute, Sweden This is a Medical University and runs courses in, for example, Translational Medicine in the Field of Autoimmunity and Assessing the Value of Medical Innovation.

The following are the large pharmaceutical companies on the WHO's 2023 Contributors List that focus on varying combinations of virology, diagnostics, medical tech, oncology and genetics.

Established in Germany in the 17th century, Merck & Co.Inc., is now American. Their research is in vaccines, infectious diseases, cardio-metabolic disorders and cancers.

Currently, it is working with Moderna trialling the use of mRNA tech's use in cancer treatment.

Moderna claims to be 'delivering on the promise of mRNA science to create a new generation of transformative medicines for patients ... relentlessly working to grow our cancer therapeutic modality by discovering mRNA medicines that harness the body's immune system to identify and kill cancer cells in the same way the immune system identifies and targets infections' and attempting the 'creation of individualized, mRNA-based personalized cancer vaccines that deliver individualized medicine to one patient at a time.' Investors/shareholders in Merck: Vanguard Group, BlackRock Inc., State Street Corpo,, Morgan Stanley, Bank of America.

Merck KgaA is a German multinational science and tech company with 63,000 employees over 65 countries. The following describes some of Merck KgaA's work:

Pandemic preparedness


mRNA development and manufacture

And some concerns -

Gilead Sciences Inc., , Glaxo Smith Kline GSK state that their 'goal must be to make adult vaccination the new standard of care.' Novartis is a Swiss company that collaborated with Pfizer and BioNTech to make mRNA jabs and did not declare safety issues with their drug Entresto.

Revvity Inc. is an American company dealing in life sciences and diagnostics. The business is focussed on selling to pharma and biotech industries and making use of new cell or gene therapy developments. Hovid Berhard is a global pharma company.

In 2024, Britain is committed to a substantial financial contribution to the WHO.

We await the outcome of ongoing deliberations to see whether public health policies which are democratic and based on true science prevail, or whether the WHO will promote policies informed by corrupt science, the greed of multinationals and the authoritarian tendency of some very wealthy people planning their unelected and all-powerful World Government. 

Font size: +

Contact us

Director : Robert Oulds
Tel: 020 7287 4414
Chairman: Barry Legg
The Bruges Group
246 Linen Hall, 162-168 Regent Street
London W1B 5TB
United Kingdom
Founder President :
The Rt Hon. the Baroness Thatcher of Kesteven LG, OM, FRS 
Vice-President : The Rt Hon. the Lord Lamont of Lerwick,
Chairman: Barry Legg
Director : Robert Oulds MA, FRSA
Washington D.C. Representative : John O'Sullivan CBE
Founder Chairman : Lord Harris of High Cross
Head of Media: Jack Soames